# Contact Wolverine Store: Editorial Corrections on the BPC-157 TB-500 Record

> Contact Wolverine Store about the BPC-157 TB-500 editorial archive. For corrections and source questions only — we are not a clinic, not a vendor, and we do not give medical advice.

Reach the editorial desk about a citation, a source, or a correction to the BPC-157 TB-500 record. We do not provide medical, dosing, or purchasing guidance.

## What we can help with

This contact channel is for the BPC-157 TB-500 editorial archive: corrections to a citation, questions about a source we cited, or a pointer to a study we should read. We are an independent editorial project, not a clinic and not a vendor, so a few requests are out of scope.

We cannot recommend a dose, a protocol, a cycle, or a route — those are not in this site's remit and no validated human dose exists for the blend in any case. We do not sell, supply, or source any peptide, and we cannot direct you to anyone who does. We do not provide medical or legal advice; the regulatory material on this site is general information about the landscape, drawn from the FDA record.

## Use the form

Send a message using the form below. Include the page and the reference number where relevant — for example, a citation on the [latest BPC-157 TB-500 research](/recent-research) page — so a correction can be checked against the source quickly. Editorial messages only; this is not a clinical or commercial inbox.

---

Two peptides indexed as one data store — BPC-157 and TB-500 each filed under its own studies and its own 503A status, the synergy entry kept empty because no controlled combination trial exists; an editorial archive, not a clinic, not a vendor, not a prescription.